BrainScope Company, Inc. Announces Executive Appointments With Deep Experience In Key Areas Of Growth

BETHESDA, Md.--(BUSINESS WIRE)--BrainScope Company, Inc., a privately held neurotechnology company with an initial focus on traumatic brain injury (TBI) and concussion assessment, announced today a series of executive appointments designed to build upon the company's strong progress. The appointments include: Dr. Leslie Prichep, hired as Chief Scientific Officer; Kerstin Schultz, hired as President and Chief Operating Officer; Laurie Silver, promoted to Chief Financial Officer; and Angad Singh, hired as Chief Technology Officer.

Suggested Articles

Galecto picked up $64 million to push its lead lung disease treatment toward an approval in Europe and fund midstage studies for its other programs.

The financing, which attracted support from Roche Venture Fund, sets Palladio up to test its vasopressin V2 receptor antagonist in a kidney disease.

A new atlas of 500,000 cardiac cells could help researchers better understand how a healthy heart operates—and what goes wrong in heart disease.